ReviewNanomaterials (Basel, Switzerland)2025
Graphene-Based Plasmonic Antenna for Advancing Nano-Scale Sensors.
Review in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The integration of two-dimensional graphene with gold nanostructures has significantly advanced surface plasmon resonance (SPR)-based optical biosensors, due to graphene's exceptional optical, electronic, and surface properties. This review examines recent developments in graphene-based hybrid nanomaterials designed to enhance SPR sensor performance. The synergistic combination of graphene and other functional materials enables superior plasmonic sensitivity, improves biomolecular interaction, and enhances signal transduction. Key focus areas include the fundamental principle of graphene-enhanced SPR, the functional advantages of graphene hybrid platforms, and their recent applications in detecting biomolecules, disease biomarkers, and pathogens. Finally, current limitations and potential future perspectives are discussed, highlighting the transformative potential of these hybrid nanomaterials in next-generation optical biosensing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.